Iron and Sex Cross Paths in the Heart

Cardiovascular‐related mortality accounts for >600 000 deaths per year and is the leading cause of death in the United States.[1][1] In addition to factors such as age; a high‐fat, high‐glucose diet; exercise; and certain comorbidities, male sex is independently associated with higher

• Publication year

  2017

• Venue

  Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease

• Publication date

  2017-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/JAHA.116.005459PMID 28115313PMCID 5523648
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Females Are Protected From Iron‐Overload Cardiomyopathy Independent of Iron Metabolism: Key Role of Oxidative Stress

  2017influential reference
• Getting to the "Heart" of Cardiac Disease by Decreasing Mitochondrial Iron.

  2016cited by this paper
• Deaths: Final Data for 2014.

  2016cited by this paper
• Reduction in mitochondrial iron alleviates cardiac damage during injury

  2016cited by this paper
• Re: Testosterone Products: Drug Safety Communication - FDA Cautions about Using Testosterone Products for Low Testosterone due to Aging; Requires Labeling Change to Inform of Possible Increased Risk of Heart Attack and Stroke.

  2015cited by this paper
• Disordered vascular compliance in haemochromatosis

  2014cited by this paper
• Prooxidant Mechanisms in Iron Overload Cardiomyopathy

  2013cited by this paper
• Estradiol exerts antiapoptotic effects in skeletal myoblasts via mitochondrial PTP and MnSOD.

  2013cited by this paper
• Efficacy of vitamin and antioxidant supplements in prevention of cardiovascular disease: systematic review and meta-analysis of randomised controlled trials

  2013cited by this paper
• Cushing syndrome secondary to a thymic carcinoid tumor due to multiple endocrine neoplasia type 1.

  2011cited by this paper
• Sex/gender differences in cardiovascular disease prevention: what a difference a decade makes.

  2011cited by this paper
• The parathyroid glands: what the endocrine surgeon should know.

  2011cited by this paper
• American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of menopause.

  2011cited by this paper
• Conditional deletion of ferritin H in mice induces loss of iron storage and liver damage

  2009cited by this paper
• Nutritional iron deficiency.

  2007cited by this paper
• The myths and realities of hemochromatosis.

  2007cited by this paper
• Genistein, a soy isoflavone, up‐regulates expression of antioxidant genes: involvement of estrogen receptors, ERK1/2, and NFκB

  2006cited by this paper
• Estrogen is associated with improved survival in aging women with congestive heart failure: analysis of the vesnarinone studies.

  2000cited by this paper
• Molecular pathogenesis of Friedreich ataxia.

  1999cited by this paper
• Epidemiology, clinical spectrum and prognosis of hemochromatosis.

  1994cited by this paper
• Progress in Iron Research

  1994cited by this paper

• Sex Differences in Cardiomyopathies

  2026cites this paper
• The role of genetically predicted serum iron levels on neurodegenerative and cardiovascular traits

  2024cites this paper
• Light and Heavy Ferritin Chain Expression in The Liver and Kidneys of Wistar Rats: Aging, Sex Differences, and Impact of Gonadectomy

  2022cites this paper
• Role of iron homeostasis in the heart

  2021cites this paper
• Balance of cardiac and systemic hepcidin and its role in heart physiology and pathology

  2018cites this paper
• Strategies to increase the use of forearm approach during coronary angiography and interventions.

  2018cites this paper
• Iron induced RNA‐oxidation in the general population and in mouse tissue

  2018cites this paper